💊Kyowa Hakko Kirin,抗Ccr4人源化抗体验收申请,用于欧洲批准的Mogum Lysumab 20171027 💊Kyowa Hakko K 10/27/17 FridayBy Tokio X'press EMA, Pharmaceutical kyowa-kirin